Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Webinars / 2022 / Connecting Patients Everywhere to Precision Oncology
Thermo Fisher Scientific Diagnostics Genetics and epigenetics Oncology Precision medicine

Connecting Patients Everywhere to Precision Oncology

Genomic profiling in precision oncology is transforming cancer care for your patients.

05/26/2022 17:00 CET

Share

View On-Demand

May 26th, 2022 - 17:00 CET

Genomic profiling in precision oncology is transforming cancer care for your patients.

But long waiting periods for biomarker test results from the lab can delay therapy decisions, with potential consequences for the patient’s outcomes.

Join us live on May 26, 2022 to hear about a new development in NGS biomarker testing which will enable a broad spectrum of laboratories to produce fast, clinically relevant biomarker data and enable clinicians to make timely therapy based on complete, relevant information.

In this webinar you will:

  • Learn about a new NGS test for precision oncology biomarker testing based on an end-to-end NGS workflow solution which can deliver results in as little as 24 hours.

  • Hear results of a multicentric study evaluating performance of the test in development.

  • Hear, from oncologists’ point of view, about the importance of timely availability of all clinically relevant biomarker data for the therapy management and potentially clinical outcomes of the oncology patients

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

More Webinars

Diagnostics Infectious Disease Omics Biochemistry and molecular biology

March 23, 2023

Using Single-Cell Sequencing to Investigate Murine COVID-19 Mortality

Subspecialties Oncology

December 1, 2022

Understanding the immune landscape of non-muscle invasive bladder cancer (NMIBC) and its influence on BCG immunotherapy

Diagnostics Omics

December 2, 2022

Unlocking Precision Oncology with Genomics - ESMO Roundtable

False

Advertisement

Recommended

False

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.